S 527introduced119th Congress

Prescription Pricing for the People Act of 2025

Introduced Feb 11, 2025Senate billPolicy area: CommerceLast action Apr 10, 2025Sponsor: Chuck Grassley(R-IA)

tradeCommerce

Judiciary Committee

Ask about this Build timeline Compare Export source pack

Official Congress record Open in Network Lab Trace connections

Official summaryUpdated Apr 10, 2025

What the bill does

Prescription Pricing for the People Act of 20 25 This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs. The report must address whether pharmacy benefit managers (PBMs) (1) reimburse pharmacies owned by the PBM at a higher price than other pharmacies, and (2) implement formulary designs to increase the market share of higher-cost prescription drugs or depress the market share of lower-cost prescription drugs. The FTC also must provide recommendations to increase transparency in the supply chain, prevent anticompetitive practices, and ensure that consumers benefit from cost savings or efficiencies that result from mergers and consolidations. Additionally, the FTC must report the number and nature of complaints the FTC receives relating to an allegation of anticompetitive conduct by a manufacturer of a sole-source drug.

Latest official action

Placed on Senate Legislative Calendar under General Orders. Calendar No. 42.

Lobbying Filings Citing It

$35.1M

Reported on Those Filings, All Issues

Lobbying Clients

Recorded Votes

Timeline

Feb 11, 2025bill

Bill introduced

Apr 18, 2025lobbying

Lobbying filed by AARP

Apr 21, 2025lobbying

Lobbying filed by AMERICAN MEDICAL ASSOCIATION

Apr 21, 2025lobbying

Lobbying filed by PFIZER INC.

Apr 21, 2025lobbying

Lobbying filed by PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION

Jul 18, 2025lobbying

Official Congressional Actions

Apr 10, 2025Calendars

Placed on Senate Legislative Calendar under General Orders. Calendar No. 42.

View official action

Apr 10, 2025Committee

Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.

Judiciary Committee

View official action

Apr 10, 2025Committee

Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.

Judiciary Committee

View official action

Apr 3, 2025Committee

Committee on the Judiciary. Ordered to be reported without amendment favorably.

Lobbying Activity

Registrant	Client	Amount	Filed	Period	Issues
AMERICAN MEDICAL ASSOCIATION	AMERICAN MEDICAL ASSOCIATION	$8.0M	Apr 21, 2025	2025Q1	BUDEDUHCR
AARP	AARP	$6.6M	Apr 18, 2025	2025Q1	HCRMMMAGR
AMERICAN MEDICAL ASSOCIATION	AMERICAN MEDICAL ASSOCIATION

About this page

The lobbying table lists Senate LDA quarterly reports (LD-2) that cite this bill by number and cover a quarter of the 119th Congress. An LD-2 names a bill as “H.R. 1234” with no Congress, so a report on another Congress, which can only concern a different bill with the same number, is left out, even when it was filed after this Congress began. The amount is what the registrant reported for the whole filing, across every issue on it, not spending on this bill. Official actions and the bill summary come from Congress.gov, and votes from the roll-call record. This page no longer pairs the bill with members' stock trades: matching lobbying clients to traded companies by name, and trades to a bill by date, is not something the records establish.